Delivery Order SPE2DB25D3108-SPE2DB25FPDYM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) under a firm fixed-price contract valued at $2,458.96. The award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30 count) with a contract ceiling value of $2,724.15 under a firm fixed-price arrangement. The award, issued on November 24, 2025, with an ultimate completion date of November 25, 2025, represents a non-set-aside, competitively awarded delivery order. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count units) valued at $3,409.62 under a firm fixed price contract. This non-competitive, non-set-aside delivery order was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency has awarded a delivery order valued at $2,401.31 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets in quantities of 30 units. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by June 20, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a $2,278.58 delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Armodafinil 250 mg, with an ultimate completion date of September 18, 2025. This contract represents a competitively awarded, firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (quantity 30) on November 6, 2025, with a ceiling value of $1,148.90 and an ultimate completion date of November 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count) with a ceiling value of $3,549.59 under a firm fixed-price contract type. The award, issued on October 21, 2025, with an ultimate completion date of October 22, 2025, represents a non-competitive delivery order executed without a set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and functions as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,779.24 to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,713.10 to AmerisourceBergen Drug Corp for 30-count tablets of Armodafinil 250 mg. The contract is firm fixed price with no set-aside designation and was awarded on December 8, 2025, with an ultimate completion date of December 9, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency has awarded a delivery order valued at $2,495.25 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count packages). The contract is a firm fixed-price delivery order with an ultimate completion date of November 7, 2025, and was competitively awarded without set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB25FPDYMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count packaging) with a contract ceiling value of $3,344.70. This non-set-aside, firm fixed-price delivery order was awarded on September 16, 2025, with an ultimate completion date of September 17, 2025. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company has demonstrated its capability to fulfill federal procurement requirements through competitive awards across multiple therapeutic domains, including neurological, pain management, and specialty medications. As a child contract under the broader SPE2DX prime IDC, this delivery order represents a routine pharmaceutical supply transaction supporting the Defense Health Agency and other federal healthcare customers worldwide. The DLA's Medical Supply Chain continues to leverage AmerisourceBergen's extensive distribution network as part of its strategy to ensure reliable pharmaceutical availability across the global military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 9/16/25 |